You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)

Article metrics

Article menu

Download PDFPDF

XML
Imaging
Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)

 

Online download statistics by month:

Online download statistics by month: January 2020 to March 2024

AbstractFullPdf
Jan 202024322078
Feb 2020591576152
Mar 202023222462
Apr 202018818653
May 202022922736
Jun 202017317034
Jul 202021421176
Aug 202015214752
Sep 202020220038
Oct 202024023644
Nov 202019619435
Dec 202021520941
Jan 202121721539
Feb 202116916934
Mar 202125224443
Apr 202120320342
May 202118418037
Jun 202117117025
Jul 202112912928
Aug 20211038964
Sep 2021128118130
Oct 2021129120159
Nov 202117216181
Dec 202113613065
Jan 202213713387
Feb 2022898271
Mar 2022858946
Apr 2022877441
May 2022645837
Jun 2022807835
Jul 2022766733
Aug 202210310029
Sep 2022757233
Oct 2022717035
Nov 2022887846
Dec 2022837122
Jan 2023727118
Feb 2023938933
Mar 202311711835
Apr 202310710743
May 202316015938
Jun 202311911638
Jul 202310810523
Aug 2023878320
Sep 2023938424
Oct 202317217142
Nov 202311911849
Dec 20231079531
Jan 2024666324
Feb 20241188023
Mar 202414113753
Total758572962457